Join
Live feed
·
PRReleasevia Quantisnow
Zymeworks Inc. logo

Zymeworks Presents New Data from Multiple Preclinical and Clinical Development Programs at the 2023 American Association for Cancer Research Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
ZYME· Zymeworks Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYME (Zymeworks Inc.) and more on Quantisnow.